口腔癌的恶性转变率在现场
Andrew Meci1, Neerav Goyal1,2, David Goldenberg1,2
1The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
The Laryngoscope
|August 9, 2025
概括
口腔瘤 in situ (OCIS) 的恶性转化率很高,可转化为侵袭性口腔状细胞癌 (OSCC). 及时诊断和治疗至关重要,因为转变可以在15个月内发生.
科学领域:
- 在瘤学瘤学.
- 口腔医学是指口腔医学.
- 癌症研究 癌症研究
背景情况:
- 口腔瘤 in situ (OCIS) 是一种前入侵性病变,有可能发展为入侵性口腔状细胞癌 (OSCC).
- 这种恶性转变的确切速率和时间表尚不清楚.
- 了解这种进展对于及时的临床干预至关重要.
研究的目的:
- 为了研究OCIS的恶性转化率到OSCC.
- 为了确定这个进展的时间框架.
- 分析OCIS患者的生存结果.
主要方法:
- 在2008年至2018年期间被诊断患有OCIS的4130名患者的回顾性队列分析.
- 使用了TrinetX研究数据库,随访时间长达5年.
- 将OSCC转化率与年龄相匹配的对照队列进行比较.
主要成果:
- 在5年内,OCIS恶性转化率达到56.8%,平均转化时间为15个月.
- 与对照组相比,患有OCIS的患者患OSCC的风险增加了234.9倍 (p < 0.01).
- 对于OCIS,卡普兰-梅尔5年生存概率为74.7%.
结论:
- 在OCIS中,呈现出高进展率的侵袭性OSCC.
- 快速的转变强调了迅速诊断和治疗的必要性.
- 早期发现和管理对于改善患者的治疗结果至关重要.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K


